Your Patients Can't Find Femring — Here's How You Can Help

You've prescribed Femring (Estradiol Acetate vaginal ring) for a patient with moderate-to-severe menopausal symptoms, and she's calling back to say her pharmacy doesn't have it. This is a common scenario — and one that costs your practice time and your patients frustration.

Femring is a brand-name-only product with no generic equivalent, a cash price exceeding $900 per ring, and limited pharmacy stocking. But with the right workflow, you can help patients get their medication filled with less back-and-forth. Here's how.

Current Availability: What You Need to Know

Femring is still being manufactured by Millicent Pharma and is not listed as an FDA shortage. However, practical access remains challenging:

• Most large chain pharmacies (CVS, Walgreens, Rite Aid) do not routinely stock Femring due to its low volume and high unit cost
• Wholesaler inventory can be inconsistent, leading to order delays even when a pharmacy agrees to special-order it
• Some regions have better availability than others, depending on local demand and distributor relationships

Understanding this landscape helps set realistic expectations for both your staff and your patients.

Why Patients Can't Find Femring

The factors are straightforward but worth reviewing:

1. No generic: A single manufacturer means a single supply chain with no redundancy
2. High cost ($895-$1,100/ring): Pharmacies avoid tying up capital in slow-moving, expensive inventory
3. Low prescription volume: Most pharmacies see only a handful of Femring prescriptions per year, if any
4. Insurance barriers: Some plans require prior authorization or step therapy, adding delays that compound the access problem

What Providers Can Do: 5 Practical Steps

Step 1: Verify Availability Before Sending the Prescription

The most impactful thing you can do is check whether a pharmacy has Femring before sending the prescription. This prevents the frustrating cycle of patients driving to pharmacies only to be turned away.

Medfinder for Providers lets you or your staff search for Femring availability by location. Integrate this into your prescribing workflow — a 60-second search can save your patient days of phone calls.

Step 2: Build a Short List of Femring-Friendly Pharmacies

Over time, identify 2-3 pharmacies in your area that reliably stock or can quickly order Femring. These tend to be:

• Independent pharmacies with flexible ordering capabilities
• Specialty pharmacies focused on women's health or hormone therapy
• Mail-order pharmacies affiliated with major insurance plans

Keep this list in your EHR or practice resource folder so any prescriber or staff member can reference it.

Step 3: Proactively Address Insurance Barriers

If your patient's plan requires prior authorization for Femring, submit it at the time of prescribing — don't wait for a pharmacy rejection. Key documentation points:

• Patient has moderate-to-severe vasomotor symptoms requiring systemic estrogen
• Low-dose vaginal estrogen products (Estring, Vagifem, Imvexxy) are not clinically equivalent — they don't provide systemic estrogen levels
• Patient's symptom severity and impact on quality of life
• Any prior trials of alternative therapies and their outcomes

For plans requiring step therapy, document why the stepped alternatives are insufficient (e.g., patient needs systemic, not just local, estrogen therapy).

Step 4: Discuss Cost Upfront

Many patients are surprised by Femring's price. Being upfront about cost — and offering solutions — builds trust and prevents prescription abandonment:

• Mention the cash price range ($895-$1,100) so patients aren't caught off guard
• Suggest prescription discount cards (GoodRx, SingleCare) that may reduce the price to around $870
• Check whether Millicent Pharma's savings program is currently active (previously offered through Apollo Care)
• For uninsured or underinsured patients, refer to savings resources

Step 5: Have an Alternative Ready

When Femring simply can't be obtained, be prepared to pivot. The right alternative depends on the patient's primary indication:

If the patient needs systemic estrogen (vasomotor symptoms):

• Transdermal estradiol patches (Vivelle-Dot 0.025-0.1 mg, Climara, Minivelle)
• Oral estradiol (Estrace) or conjugated estrogens (Premarin)
• Topical estradiol gel (EstroGel) or spray (Evamist)

If the patient needs vaginal estrogen only (atrophy):

• Estring (estradiol vaginal ring, 0.0075 mg/day — local only)
• Yuvafem/Vagifem (estradiol vaginal tablet — generic available)
• Imvexxy (estradiol vaginal insert)
• Premarin Vaginal Cream

If the patient cannot use estrogen:

• Veozah (fezolinetant) for vasomotor symptoms
• Osphena (ospemifene) for vaginal atrophy (SERM)

Workflow Tips for Your Practice

Integrating Femring access management into your workflow doesn't have to be complicated:

• Create a Femring protocol card — a one-page reference with preferred pharmacies, PA documentation templates, and patient handout links
• Train front desk and nursing staff to check Medfinder availability when a Femring prescription is being written
• Batch prior authorizations — if you prescribe Femring regularly, designate a staff member to handle PAs for all Femring patients
• Set 3-month follow-up reminders — since Femring is replaced quarterly, a proactive check-in ensures patients don't run out
• Share patient resources — direct patients to guides on finding Femring so they can help themselves between visits

Final Thoughts

Femring access is a solvable problem, but it requires more proactive management than most prescriptions. By verifying availability before prescribing, maintaining a list of reliable pharmacies, addressing insurance barriers upfront, and having alternatives ready, you can significantly reduce the burden on your patients and your practice.

Medfinder for Providers is designed to help with exactly this kind of challenge. For more clinical context, see our companion article on what prescribers need to know about the Femring shortage. For cost-saving resources to share with patients, visit our guide on helping patients save money on Femring.